Oscar Health (OSCR) reported Q2 earnings Thursday of $1.10 per diluted share, compared with a loss of $0.89 a year earlier.
Analysts surveyed by FactSet expected $0.40.
Revenue for the quarter ended June 30 was $4.88 billion, up from $2.86 billion a year earlier.
Analysts expected $4.73 billion.
The company said it continues to expect 2026 revenue of $18.7 billion to $19 billion. Analysts are looking for $12.48 billion.
Shares of the company rose more than 16% in recent premarket activity Thursday.
Price: $35.10, Change: $+4.99, Percent Change: +16.57%